<DOC>
	<DOCNO>NCT02454231</DOCNO>
	<brief_summary>The investigator design randomized clinical trial ( stem cell emergency life threaten arteriopathy SCELTA ) compare therapeutic efficacy auto-transplant enrich circulate EPCs ( ECEPCs ) auto-transplant BM-MNCs . ECEPCs , obtain immunoselection CD14+ CD34+ cell , BM-MNCs , inject intramuscularly affect limb patient critical limb ischemia ( CLI ) .</brief_summary>
	<brief_title>Monocentric Trial : Stem Cell Emergency Life Threatening Limbs Arteriopathy ( SCELTA )</brief_title>
	<detailed_description>Peripheral arterial disease comprise clinical spectrum extend symptoms presentation critical limb ischemia ( CLI ) , invalidate condition characterize rest pain , march inability , trophic lesion unavoidable progression major amputation , burden high mortality first year . The pathophysiology CLI often associate defect development collateral vessel angiogenesis , process refers formation new blood vessel tissue , due circulate endothelial progenitor cell ( EPCs ) vascular progenitor cell . In last year , significant improvement condition report follow bone marrow ( BM ) autotransplant autotransplant peripheral EPCs mobilize BM injection granulocyte-colony stimulatory factor ( G-CSF ) . In previous study , investigator find individually variable proportion circulate CD14+ cell express low level CD34 ( CD14+CD34low ) reveal functional phenotype EPCs . The investigator therefore design monocentric randomize clinical trial compare therapeutic efficacy BM autotransplant autotransplant population circulate CD34+ CD14+CD34low enrich close sterile immunomagnetic system ( enriched circulate EPCs ECEPCs ) , without previous EPC mobilization BM . Patients evaluate clinical parameter ABI , TBI , TCp02 autotransplant three follow-up time autotransplant ( 4 , 24 52 week ) ; also angio-TAC leg , capillaroscopy , photoplethysmography evaluate 4 , even 52 week .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<criteria>Eligible patient men woman age 40 year diagnosis CLI due atherosclerosis low extremity , define presence persistent rest pain require systemic continued analgesic treatment last 15 day and/or presence trophic lesion imputable occlude arteriopathy , anklebrachial Index ( ABI ) &lt; 0.40 ( systolic ankle pressure &lt; 5070 Hg mm ) , toe/brachial index ( TBI ) &lt; 0.40 ( big toe systolic pressure &lt; 3050 Hg mm ) , transcutaneous oxygen pressure ( TC pO2 ) &lt; 30 Hg mm . The patient consider eligible treatment enrol demonstration intravascular surgical revascularization possible , reveal ecography angioCAT , patient refuse undergo surgical treatment obtain his/her write inform consensus . Exclusion criterion : age &lt; 40 ; atherosclerotic CLI , myocardial infarction occurrence 6 month ; cardiac failure IIIIV class NYHA ; ejection fraction lower 40 % ; arterial hypertension ( &gt; 160/100 Hg mm ) uncontrolled despite usage two antihypertensive drug ; presence current chronic severe infectious disease ; osteomyelitis ; diabetes glycate hemoglobin &gt; 7.5 ; proliferative diabetic retinopathy ; hemorrhagic disorder ; nonatherosclerotic arteriopathy ; chronic airway insufficiency ( p02 &lt; 65 Hg mm , pCO2 &gt; 0.50 Hg mm ) ; renal failure ( creatinine &gt; 2mg/dl ) ; contraindication intolerance contrast medium radiologic image</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>EPC</keyword>
	<keyword>CD34+</keyword>
	<keyword>CD14+CD34low</keyword>
</DOC>